Emergency Contraceptive Pills Market 2022 | Piramal Enterprises Limited Teva Pharmaceutical Industries Ltd. Mankind Pharma Ltd. Cooper Pharma Lupin Limited

An emergency contraception is a birth control way to avoid pregnancy in women. The emergency contraception pills most probably avoid pregnancy, in the same manner, the same as standard birth control pills. The emergency contraceptive pills offered in the market are uneven and have the related purpose. Nevertheless, the efficiency of these pills, in addition to leaning towards the pills with slightest side effects, fuels the growth of the worldwide market. On the other hand, the sales of the emergency pills are likely to be hampered because of unsettled side effects which include a time limitation for intake, muscle spasms, heavy vomiting and nausea.

The worldwide sales of the emergency contraceptive pills are projected for a sluggish growth, recording a market valuation of US$ 1230 million throughout the forecast period of 2017-2022. The worldwide market is expected to record a CAGR below 3% in terms of value during the five years forecast period.

Request For Report Sample: https://www.researchreportinsights.com/report/sample/110114795/Emergency-Contraceptive-Pills-Market

Market segmentation

Analysis by product type

On the basis of product type, the market is further fragmented into progesterone pills, combination pills, estrogen pills and other products. Amongst these, the combination pills are anticipated to evolve as the highest productive fragment in the worldwide market as a result of eliminating the possibility of ectopic pregnancy. The combination pills in the global market are likely to contribute around 40% of revenue shares in 2017. However, the sales of the estrogen pills are likely to lose hold of the market by registering a CAGR of 1.5% of revenue shares along with progesterone pills.

Request Report Discount: https://www.researchreportinsights.com/report/discount/110114795/Emergency-Contraceptive-Pills-Market

Analysis by sales channel

On the basis of sales channel, the market is sub-divided into hospital pharmacies, drug store/pharmacies, online trader and other channels. The drug stores/pharmacies and hospital pharmacies are undeniably the two leading sales channels by accounting for over 70% of the revenue shares at the beginning of the forecast period. The Online sales channel is also likely to witness a considerable decline by capturing less than US$ 160 million in worldwide revenue market by 2022 end.

Analysis by region

The overall market is segmented into five key regions namely Europe, Latin America, North America, MEA and APAC. Among these regions, North America is expected to be the biggest market. However, the European and the Asia Pacific excluding Japan region are likely to lose their hold in the worldwide market.

Key Market Players

The leading companies in the worldwide emergency contraceptive pills market include

Richter Gedeon Nyrt
Bayer AG
Piramal Enterprises Limited
Teva Pharmaceutical Industries Ltd.
Mankind Pharma Ltd.
Cooper Pharma
Lupin Limited
HRA Pharma
Zhejiang Xianju Pharmaceutical Co
Pfizer Inc.

Report Analysis: https://www.researchreportinsights.com/report/rd/110114795/Emergency-Contraceptive-Pills-Market

About Us:
Research Report Insights (RRI) is a leading market intelligence and consulting firm. We deliver a host of services including custom research reports, syndicated research reports, and consulting services which are personalised in nature. RRI delivers a complete packaged solution to clients; this combines current market intelligence, technology inputs, statistical anecdotes, valuable growth insights, 360-degree view of the competitive framework, and anticipated market trends.

Contact Us:
Research Report Insights (RRI)
42 Joseph Street
Port carling P0B 1J0
Muskoka, Ontario1
Phone - +1-631-721-4201
Website: https://www.researchreportinsights.com/
Email: sales@researchreportinsights.com

This release was published on openPR.